Rapid diagnostic test approved for HIV-1, HIV-2.
Like other HIV tests, the Alere Determine HIV-1/2 Ag/Ab Combo test can detect antibodies to HIV-I, the most common type of HIV, and HIV-2 in human serum, plasma, or venous and fingerstick blood specimens.
But the new test also can distinguish acute HIV-1 infection from established HP/-i infection, if the blood specimen is positive for HIV-1 p24 antigen but negative for HIV-1 and HIV-2 antibodies.
The new test could be a crucial tool for identifying HIV-infected individuals who might not be able to be tested in traditional health care settings, said Dr. Karen Midthun director of the FDA's Center for Biologics Evaluation and Research, in a statement.
Orgenics makes the Alere Determine HIV-1 / 2 Ag/Ab Combo test.
|Printer friendly Cite/link Email Feedback|
|Publication:||Internal Medicine News|
|Date:||Sep 1, 2013|
|Previous Article:||FDA finalizes regulations defining 'gluten free' for celiac patients.|
|Next Article:||Public Citizen: malpractice payouts hit record lows.|